Is Injection Pain or an Infection After Testosterone? (TRT Q&As)
Timeline
Dr. O’Connor explains how persistent or worsening redness, tenderness, swelling, and especially fever can indicate cellulitis or another infection rather than routine post-injection pain. He stresses that worsening symptoms after several days require medical evaluation because an untreated injection-related infection can become serious.
A 44-year-old man with hypertrophic obstructive cardiomyopathy, heart failure, an implanted defibrillator, serious arrhythmias, and low testosterone asks about returning to TRT. Dr. O’Connor describes this as a highly complex case requiring close cardiology involvement and discusses cautious testosterone dosing, fluid retention, elevated red blood cells, iron-related concerns, and alternative testosterone delivery methods.
Video Summary
This mailbag discussion focuses on questions about symptom plateaus that occur after initial improvements on testosterone therapy. It explains why early gains may level off and why this does not necessarily indicate treatment failure. Stabilization is framed as a normal phase rather than a setback.
A central portion examines how expectations influence perception of benefit over time. The episode discusses diminishing returns, adaptation, and the difference between physiologic change and subjective improvement. Realistic framing is emphasized to avoid unnecessary escalation.
The closing segment integrates plateau awareness into long-term testosterone management. Ongoing reassessment, expectation alignment, and proportional decision-making are highlighted. Hormone therapy is positioned as a stabilizing intervention rather than a continuous upward trajectory.
Drug Callouts
Condition Callouts
Key Takeaways
- Symptom plateaus are a common phase of testosterone therapy.
- Early gains do not always continue indefinitely.
- Expectation management influences perceived benefit.
- Unnecessary escalation can introduce risk.
- Stabilization often reflects physiologic adaptation.